Perspectives in allergen immunotherapy: 2017 and beyond von Pfaar, O., Bonini, S., Cardona, V., Demoly, P., Jakob, T., Jutel, M., Kleine‐Tebbe, J., Klimek, L., Klysner, S., Kopp, M. V., Kuna, P., Larché, M., Muraro, A., Schmidt‐Weber, C. B., Shamji, M. H., Simonsen, K., Somoza, C., Valovirta, E., Zieglmayer, P., Zuberbier, T., Wahn, U.

Volltext

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy von Pfaar, O., Zieglmayer, P.

Volltext

Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis von Jordakieva, G., Kundi, M., Lemell, P., Zieglmayer, R., Zieglmayer, P., Jensen-Jarolim, E., Crevenna, R.

Volltext

The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial von Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Collins, L. P., Hunter, M. G., Steiner, J., Lewis, T., Payton, M. A., Perkins, C. M., Pettipher, R.

Volltext

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper von Pfaar, O., Calderon, M. A., Andrews, C. P., Angjeli, E., Bergmann, K. C., Bønløkke, J. H., Blay, F., Devillier, P., Ellis, A. K., Gerth van Wijk, R., Hohlfeld, J. M., Horak, F., Jacobs, R. L., Jacobsen, L., Jutel, M., Kaul, S., Larché, M., Larenas‐Linnemann, D., Mösges, R., Nolte, H., Patel, P., Peoples, L., Rabin, R. L., Rather, C., Salapatek, A. M., Sigsgaard, T., Thaarup, S., Yang, J., Zieglmayer, P., Zuberbier, T., Demoly, P.

Volltext

The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis von Murdoch, R. D., Bareille, P., Ignar, D., Miller, S. R., Gupta, A., Boardley, R., Zieglmayer, P., Zieglmayer, R., Lemel, P., Horak, F.

Volltext

Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy von Van Overtvelt, L., Baron‐Bodo, V., Horiot, S., Moussu, H., Ricarte, C., Horak, F., Zieglmayer, P., Zieglmayer, R., Montagut, A., Galvain, S., de Beaumont, O., Le Gall, M., Moingeon, P.

Volltext

Possible effect of landscape design on IgE recognition profiles of two generations revealed with micro‐arrayed allergens von Garib, V., Wollmann, E., Djambekova, G., Lemell, P., Kmenta, M., Berger, U., Zieglmayer, P., Valenta, R.

Volltext

Cosensitization to the 3 Nonhomologous Major Cashew Allergens Ana o 1, Ana o 2, and Ana o 3 Is Caused by IgE Cross-reactivity von Kabasser, S, Radauer, C, Eber, E, Haber, M E, Hieden, K, Zieglmayer, P, Kost, L E, Sindher, S B, Chinthrajah, S, Geiselhart, S, Hoffmann-Sommergruber, K, Nadeau, K C, Breiteneder, H, Bublin, M

Volltext

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study von Eckl‐Dorna, J., Fröschl, R., Lupinek, C., Kiss, R., Gattinger, P., Marth, K., Campana, R., Mittermann, I., Blatt, K., Valent, P., Selb, R., Mayer, A., Gangl, K., Steiner, I., Gamper, J., Perkmann, T., Zieglmayer, P., Gevaert, P., Valenta, R., Niederberger, V.

Volltext

Clinical reactivity of celery cultivars in allergic patients: Role of Api g 1 von Dölle, S., Welter, S., Ruppel, E., Lehmann, K., Schwarz, D., Jensen‐Jarolim, E., Zieglmayer, P., Franken, P., Worm, M.

Volltext

Epitope specificity determines cross‐protection of a SIT‐induced IgG4 antibody von Gadermaier, E., James, L. K., Shamji, M. H., Blatt, K., Fauland, K., Zieglmayer, P., Garmatiuk, T., Focke‐Tejkl, M., Villalba, M., Beavil, R., Keller, W., Valent, P., Durham, S. R., Gould, H. J., Flicker, S., Valenta, R.

Volltext

Intranasal Toll-like Receptor 8 Agonist (VTX-1463) Significantly Improves Symptoms of Allergic Rhinitis in a Randomized, Placebo-Controlled Trial von Horak, F, Zieglmayer, P, Zieglmayer, R, Lemell, P, Newkirk, M, Manjarrez, K, Randall, T.D, Hershberg, R

Volltext

Current Standards and Improvements in the Use of SLIT Tablets for Allergen Immunotherapy von Klimek, L., Demoly, P., Zieglmayer, P., Worm, M., Passalacqua, G., Pfaar, O.

Volltext

Clinical Validation of a house dust mite environmental challenge chamber model von Zieglmayer, P., MD, Lemell, P., PhD, Chen, K.W., PhD, Schmutz, R., MD, Zieglmayer, R, Pfaar, O., MD, Horak, F., MD, Vrtala, S., PhD

Volltext

Onset of Action of a Five Grass Pollen 300IR SLIT Tablet Evaluated in an Allergen Challenge Chamber (ACC) von Horak, F, Zieglmayer, P, Zieglmayer, R, Lemell, P, Montagut, A, Mélac, M, Galvain, S, Le Gall, M

Volltext

P401 RAPID ONSET OF ACTION OF A NOVEL BUDESONIDE NASAL SPRAY IN GRASS POLLEN ALLERGIC RHINITIS von Zieglmayer, P., Lemell, P., Unger- Manhart, N., Goessl, A., Zieglmayer, R., Prieschl- Grassauer, E.

Volltext

P451 SUPER- AND NON/LOW-RESPONDERS AMONG SUBJECTS WITH ALLERGIC RHINOCONJUNCTIVITIS RECEIVING HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET von Nelson, H., Zieglmayer, P., Bernstein, D., Zieglmayer, R., Lemell, P., Nolte, H.

Volltext

Alleviation of Allergic Rhinoconjunctivitis Symptoms in Participants Treated with a 0.005% Tacrolimus Eye-Drop Solution von Sladek, Svenja, Unger-Manhart, Nicole, Siegl, Cornelia, Dellago, Hanna, Zieglmayer, Petra U, Lemell, Patrick, Savli, Markus, Zieglmayer, René, Geitzenauer, Wolfgang, Längauer, Matthias, Prieschl-Grassauer, Eva

Volltext

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis von BAREILLE, Philippe, MURDOCH, Robert D, DENYER, Jane, BENTLEY, Jane, SMART, Kevin, YARNALL, Katy, ZIEGLMAYER, Petra, ZIEGLMAYER, René, LEMELL, Patrick, HORAK, Friedrich

Volltext